Oral absorption and presystemic first-pass effect of chlorpheniramine in rabbits
- PMID: 7341757
- DOI: 10.1007/BF01070903
Oral absorption and presystemic first-pass effect of chlorpheniramine in rabbits
Abstract
The oral absolute bioavailabilities of chloropheniramine (CPM) in four rabbits (New Zealand White, male, mean wt. 3.71 kg), averaged 0.06 +/- 0.03, 0.11 +/- 0.08, and 0.09 +/- 0.01 following a 3, 10.5, and 21 mg/kg dose, respectively. The individual bioavailability data and the AUC of one of the demethylated metabolites, desdimethyl CPM (DDCPM) obtained following different doses suggested the existence of saturable presystemic elimination. Two rabbits received an additional 10.5 mg/kg dose of CPM through portal vein infusion. Based on the oral, intraportal vein and i.v. studies, the mean extraction ratios of gut and the liver calculated for these two rabbits averaged 0.58 and 0.76, respectively. The latter value agreed well with the estimated hepatic extraction ratio from the in vitro liver homogenate study (0.89) or from the i.v. studies (0.83). The existence prehepatic first-pass effect observed in the present study was consistent with similar findings in humans and dogs.
Similar articles
-
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.Eur J Clin Pharmacol. 1982;22(4):359-65. doi: 10.1007/BF00548406. Eur J Clin Pharmacol. 1982. PMID: 7106172
-
Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration.J Pharmacokinet Biopharm. 1981 Dec;9(6):711-23. doi: 10.1007/BF01070902. J Pharmacokinet Biopharm. 1981. PMID: 7341756
-
Chlorpheniramine. II. Effect of the first-pass metabolism on the oral bioavailability in dogs.J Pharmacokinet Biopharm. 1979 Aug;7(4):383-96. doi: 10.1007/BF01062536. J Pharmacokinet Biopharm. 1979. PMID: 512844
-
Clinical pharmacokinetics of chlorpheniramine.Drug Intell Clin Pharm. 1984 Sep;18(9):701-7. doi: 10.1177/106002808401800905. Drug Intell Clin Pharm. 1984. PMID: 6383755 Review.
-
Effect of hepatic insufficiency on pharmacokinetics and drug dosing.Pharm World Sci. 1998 Oct;20(5):183-92. doi: 10.1023/a:1008656930082. Pharm World Sci. 1998. PMID: 9820880 Review.
Cited by
-
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.Eur J Clin Pharmacol. 1982;22(4):359-65. doi: 10.1007/BF00548406. Eur J Clin Pharmacol. 1982. PMID: 7106172
-
We may not measure the correct intestinal wall permeability coefficient of drugs: alternative absorptive clearance concept.J Pharmacokinet Biopharm. 1995 Jun;23(3):323-31. doi: 10.1007/BF02354288. J Pharmacokinet Biopharm. 1995. PMID: 8834199 Review.
-
Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.J Pharmacokinet Biopharm. 1983 Dec;11(6):623-40. doi: 10.1007/BF01059061. J Pharmacokinet Biopharm. 1983. PMID: 6678312
-
Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration.J Pharmacokinet Biopharm. 1981 Dec;9(6):711-23. doi: 10.1007/BF01070902. J Pharmacokinet Biopharm. 1981. PMID: 7341756